- Home
- EW
as 11-22-2024 4:00pm EST
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.
| Founded: | 1958 | Country: | United States |
| Employees: | N/A | City: | IRVINE |
| Market Cap: | 39.3B | IPO Year: | 2000 |
| Target Price: | $76.60 | AVG Volume (30 days): | 5.1M |
| Analyst Decision: | Buy | Number of Analysts: | 21 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 6.89 | EPS Growth: | 193.69 |
| 52 Week Low/High: | $58.93 - $96.12 | Next Earning Date: | 10-24-2024 |
| Revenue: | $6,314,900,000 | Revenue Growth: | 24.02% |
| Revenue Growth (this year): | 0.34% | Revenue Growth (next year): | 1.64% |
Latest Edwards Lifesciences Corporation News
EW Breaking Stock News: Dive into EW Ticker-Specific Updates for Smart Investing
Simply Wall St.
19 hours ago
Despite delivering investors losses of 39% over the past 3 years, Edwards Lifesciences (NYSE:EW) has been growing its earnings
Simply Wall St.
4 days ago
November 2024's Top Undervalued Small Caps With Insider Activity
MT Newswires
9 days ago
Edwards Lifesciences Insider Sold Shares Worth $327,843, According to a Recent SEC Filing
Medical Device Network
10 days ago
US transcatheter tricuspid valve repair market grows by over 50% since launch in Q2 2024
Simply Wall St.
10 days ago
We Like The Quality Of Edwards Lifesciences' (NYSE:EW) Earnings
Argus Research
10 days ago
EW: Lowering target price to $59.00
GuruFocus.com
14 days ago
Decoding Edwards Lifesciences Corp (EW): A Strategic SWOT Insight
Argus Research
17 days ago
EW: Lowering target price to $60.00
Compare EW vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "EW Edwards Lifesciences Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.